User Guide
Why can I only view 3 results?
You can also view all results when you are connected from the network of member institutions only. For non-member institutions, we are opening a 1-month free trial version if institution officials apply.
So many results that aren't mine?
References in many bibliographies are sometimes referred to as "Surname, I", so the citations of academics whose Surname and initials are the same may occasionally interfere. This problem is often the case with citation indexes all over the world.
How can I see only citations to my article?
After searching the name of your article, you can see the references to the article you selected as soon as you click on the details section.
 Views 18
 Downloands 7
T1-2NOMO Küçük Hücreli Dışı Akciğer Kanseri Hastalarında Primer Tümör Metabolik Aktivitesi Gizli Lenf Nodu Metastazı için Risk Faktörü müdür?
2016
Journal:  
Gazi Medical Journal
Author:  
Abstract:

Amaç: Çalışmamızın amacı, pozitron emisyon-bilgisayarlı tomografi (PET-BT) ile klinik evre 1 olarak evrelendirilmiş küçük hücreli dışı akciğer kanseri (KHDAK) hastalarında gizli lenf nodu metastazı için potansiyel risk faktörlerini incelemektir. Yöntemler: Torasik Onkoloji ünitemizde PET-BT ile klinik olarak Evre I KHDAK tanısı konmuş ve cerrahi uygulanmış, sistemik lenf nodu örneklemesi yapılmış 26 hastanın dosyaları retrospektif olarak incelendi. Hastaların demografik özellikleri, cerrahi yapılana kadar geçen süre, tümörün histolojik tipi, diferansiasyon derecesi, lokalizasyonu, PET/BT’deki çapı, cerrahi çapı ve SUVmax değeri kaydedildi. Gizli lenf nodu metastazı için olabilecek risk faktörleri incelendi. Hastalar PET/BT'deki tümörün çapı ve SUVmax değerine göre üç gruba ayrıldı: grup 1 (düşük riskli grup) T≤3 cm ve SUVmax <11.6, grup 2 (orta riskli grup) 3 cm

Keywords:

T1-2NOMO Primary tumor in noncellular lungs cancer patients Metabolic activity is a risk factor for hidden lymph nod metastasis?
2016
Author:  
Abstract:

Purpose: The aim of our study is to study potential risk factors for hidden lymph nod metastasis in patients with small noncellular lung cancer (CADR) evolved into clinical stage 1 with positron emission-computer tomography (PET-BT). Methods: In our Torasic Oncology unit with PET-BT clinically diagnosed Phase I KHDAK and the files of 26 patients with a systemic lymph nod sample were examined retrospectively. The demographic characteristics of patients, the time passed until surgery, the histological type of the tumor, the degree of differentiation, the location, the diameter in PET/BT, the surgical diameter and the value of SUVmax were recorded. The risk factors that may occur for the metastasis of the hidden lymph nodes have been studied. Patients were divided into three groups according to the diameter of the tumor in PET/BT and the value of the SUVmax: group 1 (low-risk group) T≤3 cm and SUVmax <11.6, group 2 (medium-risk group) 3 cm

Citation Owners
Information: There is no ciation to this publication.
Similar Articles












Gazi Medical Journal

Field :   Sağlık Bilimleri

Journal Type :   Uluslararası

Metrics
Article : 1.186
Cite : 525
Gazi Medical Journal